T. Sone

702 total citations
14 papers, 578 citations indexed

About

T. Sone is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Ophthalmology. According to data from OpenAlex, T. Sone has authored 14 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Ophthalmology. Recurrent topics in T. Sone's work include Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (5 papers) and Lung Cancer Research Studies (3 papers). T. Sone is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (5 papers) and Lung Cancer Research Studies (3 papers). T. Sone collaborates with scholars based in Japan, United Kingdom and United States. T. Sone's co-authors include Kazuo Kasahara, Kazuto Nishio, Hidetaka Noma, Tatsuya Mimura, Hideharu Funatsu, H Tamura, Hidetoshi Yamashita, M. Yamasaki, Hisao Tsukamoto and Hiromu K. Mishima and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and British Journal of Ophthalmology.

In The Last Decade

T. Sone

13 papers receiving 568 citations

Peers

Countries citing papers authored by T. Sone

Since Specialization

Citations

This map shows the geographic impact of T. Sone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Sone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Sone more than expected).

Fields of papers citing papers by T. Sone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Sone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Sone. The network helps show where T. Sone may publish in the future.

Co-authorship network of co-authors of T. Sone

This figure shows the co-authorship network connecting the top 25 collaborators of T. Sone. A scholar is included among the top collaborators of T. Sone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Sone. T. Sone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Concurrent intestinal plasmablastic lymphoma and diffuse large B-cell lymphoma with a clonal relationship: a case report and literature review 2024 ·Journal of Pathology and Translational Medicine ·(unknown), Kosuke Miyai, (unknown), (unknown), T. Sone, Shinichi Kobayashi, Sho Ogata, Fumihiko Kimura, Susumu Matsukuma	0
2	Ocular Volumetry Using Fast High-Resolution MRI during Visual Fixation 2012 ·American Journal of Neuroradiology ·(unknown), T. Sone, (unknown), (unknown), Keiko Otani, Yuji Akiyama, (unknown), Shuji Date, Yoshiaki Kiuchi, Kazuo Awai	3
3	Analysis of c-Met gene amplification in Japanese patients with advanced non-small cell lung cancer (NSCLC). 2011 ·Journal of Clinical Oncology ·T. Sone, Kazuo Kasahara, A. Sakai, (unknown), (unknown), M Fujimura	1
4	Macular microcirculation and macular oedema in branch retinal vein occlusion 2009 ·British Journal of Ophthalmology ·Hidetaka Noma, Hideharu Funatsu, (unknown), Seiyo Harino, Taiji Nagaoka, Tatsuya Mimura, T. Sone, Satoshi Hori	36
5	Prognostic and predictive impact of EGFR and K-ras mutation, and EGFR gene copy number in patients with advanced non-small cell lung cancer (NSCLC) who received first-line cytotoxic chemotherapy 2009 ·Journal of Clinical Oncology ·Yuichi Tambo, Kazuo Kasahara, T. Sone, Hideharu Kimura, A. Sakai, Tomoyuki Araya, Akihiko Ueda, M Fujimura, Shinji Nakao	2
6	Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA) 2007 ·British Journal of Cancer ·Hideharu Kimura, (unknown), Kazuo Kasahara, T. Sone, Tomoyuki Araya, (unknown), Fumiaki Koizumi, Kazuto Nishio, K Miyamoto, M Fujimura, Shinji Nakao	171
7	EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib 2006 ·British Journal of Cancer ·Hideki Kimura, Yutaka Fujiwara, T. Sone, Hideo Kunitoh, Tomohide Tamura, Kazuo Kasahara, Kazuto Nishio	105
8	Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion 2006 ·Eye ·Hidetaka Noma, Hideharu Funatsu, M. Yamasaki, Hisao Tsukamoto, Tatsuya Mimura, T. Sone, (unknown), H Tamura, Hidetoshi Yamashita, Atsushi Minamoto, Hiromu K. Mishima	226
9	MRI appearance of primary giant ovarian leiomyoma in a hysterectomised woman 2006 ·British Journal of Radiology ·Tsutomu Tamada, T. Sone, (unknown), Hideyuki Higashi, Hideaki Miyoshi, (unknown), Adam Kenji Yamamoto, (unknown)	14
10	Correlation between epidermal growth factor receptor gene status and clinical outcome of gefitinib in Japanese patients with non-small cell lung cancer 2006 ·Journal of Clinical Oncology ·Kazuo Kasahara, T. Sone, Hideharu Kimura, Kazuto Nishio, Tomohide Tamura, Kazuhiko Shibata, (unknown), Akihiro Yoshimoto, M Fujimura, S Nakao	2
11	A phase II study of gefitinib monotherapy for chemotherapy-naive patients with non-small cell lung cancer 2005 ·Journal of Clinical Oncology ·Kazuo Kasahara, Hideharu Kimura, Akihiro Yoshimoto, T. Sone, Kazuhiko Shibata, Yoshihisa Ishiura, Hideo Kunitoh, Kazuto Nishio, Tomohide Tamura, M Fujimura, (unknown)	10
12	A phase II trial of weekly paclitaxel (P) and gefitinib (G) in patients (pts) with gefitinib-refractory or -resistant non-small cell lung cancer (NSCLC) 2004 ·Journal of Clinical Oncology ·Kazuo Kasahara, T. Sone, Hideharu Kimura, Akihiro Yoshimoto, Tomoyuki Araya, Kazuo Iwasa, (unknown), (unknown), M Fujimura, Shinji Nakao	2
13	A phase II trial of weekly paclitaxel (P) and gefitinib (G) in patients (pts) with gefitinib-refractory or -resistant non-small cell lung cancer (NSCLC) 2004 ·Journal of Clinical Oncology ·Kazuo Kasahara, T. Sone, Hideharu Kimura, Akihiro Yoshimoto, Tomoyuki Araya, Kazuo Iwasa, (unknown), (unknown), M Fujimura, Shinji Nakao	1
14	[Clinical study on the measurement of squamous cell carcinoma (SCC)--related antigen in SCC]. 1985 ·PubMed ·M Fukunaga, Noriyuki Otsuka, T. Sone, (unknown), (unknown), (unknown), Masahiko Yanagi, (unknown), T Tomomitsu, Ryoji Morita	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact